Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.380
-0.027 (-1.88%)
May 6, 2026, 11:06 AM EDT - Market open
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $58.88 million as of May 6, 2026. Its market cap has increased by 95.79% in one year.
Market Cap
58.88M
Enterprise Value
58.63M
1-Year Change
95.79%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $58.88M, an increase of 3,212.22%. That is a compound annual growth rate of 168.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 60.01M | 1.86% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 73.32M |
| Actuate Therapeutics | 69.95M |
| OS Therapies | 69.78M |
| MediciNova | 68.91M |
| Impact BioMedical | 68.51M |
| Immutep | 67.65M |
| Filana Therapeutics | 67.63M |
| ImageneBio | 63.64M |